Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells: Correlation with decreased H1 kinase activity
- 17 November 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (10) , 1831-1840
- https://doi.org/10.1016/0006-2952(93)90590-s
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275JNCI Journal of the National Cancer Institute, 1992
- The cdc25 M-phase inducer: An unconventional protein phosphataseCell, 1992
- cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2Cell, 1991
- The cdc25 protein contains an intrinsic phosphatase activityCell, 1991
- Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotesCell, 1991
- Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites.The EMBO Journal, 1991
- Cyclin activation of p34cdc2Cell, 1990
- Universal control mechanism regulating onset of M-phaseNature, 1990
- Reversible tyrosine phosphorylation of cdc2: Dephosphorylation accompanies activation during entry into mitosisCell, 1989
- An antiinflammatory cum immunomodulatory piperidinylbenzopyranone from dysoxylum binectariferum : isolation, structure and total synthesisTetrahedron, 1988